Assessing depression recurrence, cognitive burden, and neurobiological homeostasis in late life: Design and rationale of the REMBRANDT study
Warren D. Taylor(Duke University), Carmen Andreescu(University of Pittsburgh), Robert T. Krafty(Emory University), Jason Hassenstab(Washington University in St. Louis), Sarah M. Szymkowicz(Vanderbilt University Medical Center), Helmet T. Karim(University of Pittsburgh), Bennett A. Landman(Vanderbilt University), Layla Banihashemi(University of Pittsburgh), Meryl A. Butters, Olusola Ajilore(Illinois College), Brian D. Boyd(Vanderbilt University Medical Center), Claire Ryan(Vanderbilt University Medical Center)
Cited by 17
Related Papers
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
|Science Translational Medicine|2016|747
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483
Effects of signal‐to‐noise ratio on the accuracy and reproducibility of diffusion tensor imaging–derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T
|Journal of Magnetic Resonance Imaging|2007|371
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
|Nature Medicine|2021|365